Trials / Completed
CompletedNCT03585959
superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology
A Post-market Feasibility Study Evaluating Location Accuracy Using the superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology in Subjects Undergoing Lung Lesion Biopsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medtronic - MITG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigation is to confirm the clinical accuracy of the superDimension™ Navigation System Version 7.2 with Fluoroscopic Navigation Technology.
Detailed description
The primary objective of this post-market feasibility study is to confirm the location accuracy of the local registration feature of the superDimension™ Navigation System Version 7.2 in subjects undergoing lung lesion biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | superDimension™ Navigation System Version 7.2 | superDimension™ Navigation System Version 7.2 with Fluoroscopic Navigation Technology in subjects undergoing lung lesion biopsy |
Timeline
- Start date
- 2018-08-03
- Primary completion
- 2019-02-13
- Completion
- 2019-02-18
- First posted
- 2018-07-13
- Last updated
- 2020-04-29
- Results posted
- 2020-04-07
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03585959. Inclusion in this directory is not an endorsement.